ADVAIR DISKUS: Clinical Trials

5 trials of ADVAIR DISKUS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Unknown 1

Follow ADVAIR DISKUS: new trials by email Literature Review of ADVAIR DISKUS trials Research Report on ADVAIR DISKUS

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUSĀ® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR DISKUSĀ® 100/50 mcg inhalation powder pre-dispensed/GSK, Placebo - Asthma
Phase 3CompletedRespirent Pharmaceuticals Co Ltd.4512018-10-022020-07-07
A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50
Test Product, Reference Product, Placebo - Asthma
Phase 3UnknownAmneal Ireland Limited12042018-10-012018-06-20
Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
Fp MDPI, FS MDPI, FLOVENT HFA - Persistent Asthma
Phase 3CompletedTeva Branded Pharmaceutical Products R&D, Inc.7582014-07-012021-11-09
Symbicort Onset of Action 1
budesonide/formoterol (Symbicort), fluticasone/salmeterol (Advair Diskus), albuterol (Ventolin) - Asthma
Phase 3CompletedAstraZeneca482003-04-012009-04-06
Symbicort Onset of Action 2
budesonide/formoterol, fluticasone/salmeterol, albuterol - Asthma
Phase 3CompletedAstraZeneca482003-03-012011-01-24

Conditions studied

Asthma (4)

Sponsors

AstraZeneca (2)  ·  Amneal Ireland Limited (1)  ·  Respirent Pharmaceuticals Co Ltd. (1)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (1)

Countries

Greece (1)  ·  United States (1)

Top investigators

Catherine Bonuccelli (2)  ·  Athanasios Konstantinidis, Ass.Professor (1)  ·  Irshad Haque (1)

Results publications

PMID 27216137, PMID 28540844, PMID 36472162